Cargando…
Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance
BACKGROUND: Providing healthcare professionals with health surveillance data aims to support professional and organisational behaviour change. The UK Five Year Antimicrobial Resistance (AMR) Strategy 2013 to 2018 identified better access to and use of surveillance data as a key component. Our aim wa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053143/ https://www.ncbi.nlm.nih.gov/pubmed/32122326 http://dx.doi.org/10.1186/s12889-020-8383-8 |
_version_ | 1783502983606042624 |
---|---|
author | Al-Haboubi, Mustafa Trathen, Andrew Black, Nick Eastmure, Elizabeth Mays, Nicholas |
author_facet | Al-Haboubi, Mustafa Trathen, Andrew Black, Nick Eastmure, Elizabeth Mays, Nicholas |
author_sort | Al-Haboubi, Mustafa |
collection | PubMed |
description | BACKGROUND: Providing healthcare professionals with health surveillance data aims to support professional and organisational behaviour change. The UK Five Year Antimicrobial Resistance (AMR) Strategy 2013 to 2018 identified better access to and use of surveillance data as a key component. Our aim was to determine the extent to which data on antimicrobial use and resistance met the perceived needs of health care professionals and policy-makers at national, regional and local levels, and how provision could be improved. METHODS: We conducted 41 semi-structured interviews with national policy makers in the four Devolved Administrations and 71 interviews with health care professionals in six locations across the United Kingdom selected to achieve maximum variation in terms of population and health system characteristics. Transcripts were analysed thematically using a mix of a priori reasoning guided by the main topics in the interview guide together with themes emerging inductively from the data. Views were considered at three levels - primary care, secondary care and national - and in terms of availability of data, current uses, benefits, gaps and potential improvements. RESULTS: Respondents described a range of uses for prescribing and resistance data. The principal gaps identified were prescribing in private practice, internet prescribing and secondary care (where some hospitals did not have electronic prescribing systems). Some respondents under-estimated the range of data available. There was a perception that the responsibility for collecting and analysing data often rests with a few individuals who may lack sufficient time and appropriate skills. CONCLUSIONS: There is a need to raise awareness of data availability and the potential value of these data, and to ensure that data systems are more accessible. Any skills gap at local level in how to process and use data needs to be addressed. This requires an identification of the best methods to improve support and education relating to AMR data systems. |
format | Online Article Text |
id | pubmed-7053143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70531432020-03-10 Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance Al-Haboubi, Mustafa Trathen, Andrew Black, Nick Eastmure, Elizabeth Mays, Nicholas BMC Public Health Research Article BACKGROUND: Providing healthcare professionals with health surveillance data aims to support professional and organisational behaviour change. The UK Five Year Antimicrobial Resistance (AMR) Strategy 2013 to 2018 identified better access to and use of surveillance data as a key component. Our aim was to determine the extent to which data on antimicrobial use and resistance met the perceived needs of health care professionals and policy-makers at national, regional and local levels, and how provision could be improved. METHODS: We conducted 41 semi-structured interviews with national policy makers in the four Devolved Administrations and 71 interviews with health care professionals in six locations across the United Kingdom selected to achieve maximum variation in terms of population and health system characteristics. Transcripts were analysed thematically using a mix of a priori reasoning guided by the main topics in the interview guide together with themes emerging inductively from the data. Views were considered at three levels - primary care, secondary care and national - and in terms of availability of data, current uses, benefits, gaps and potential improvements. RESULTS: Respondents described a range of uses for prescribing and resistance data. The principal gaps identified were prescribing in private practice, internet prescribing and secondary care (where some hospitals did not have electronic prescribing systems). Some respondents under-estimated the range of data available. There was a perception that the responsibility for collecting and analysing data often rests with a few individuals who may lack sufficient time and appropriate skills. CONCLUSIONS: There is a need to raise awareness of data availability and the potential value of these data, and to ensure that data systems are more accessible. Any skills gap at local level in how to process and use data needs to be addressed. This requires an identification of the best methods to improve support and education relating to AMR data systems. BioMed Central 2020-03-02 /pmc/articles/PMC7053143/ /pubmed/32122326 http://dx.doi.org/10.1186/s12889-020-8383-8 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Al-Haboubi, Mustafa Trathen, Andrew Black, Nick Eastmure, Elizabeth Mays, Nicholas Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance |
title | Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance |
title_full | Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance |
title_fullStr | Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance |
title_full_unstemmed | Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance |
title_short | Views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance |
title_sort | views of health care professionals and policy-makers on the use of surveillance data to combat antimicrobial resistance |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053143/ https://www.ncbi.nlm.nih.gov/pubmed/32122326 http://dx.doi.org/10.1186/s12889-020-8383-8 |
work_keys_str_mv | AT alhaboubimustafa viewsofhealthcareprofessionalsandpolicymakersontheuseofsurveillancedatatocombatantimicrobialresistance AT trathenandrew viewsofhealthcareprofessionalsandpolicymakersontheuseofsurveillancedatatocombatantimicrobialresistance AT blacknick viewsofhealthcareprofessionalsandpolicymakersontheuseofsurveillancedatatocombatantimicrobialresistance AT eastmureelizabeth viewsofhealthcareprofessionalsandpolicymakersontheuseofsurveillancedatatocombatantimicrobialresistance AT maysnicholas viewsofhealthcareprofessionalsandpolicymakersontheuseofsurveillancedatatocombatantimicrobialresistance |